IDEAYA Biosciences Quarterly Balance Sheet
NASDAQ: IDYAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
IDEAYA Biosciences financial position
As of Jun 30, 2026, IDEAYA Biosciences reported total assets of $1.31 billion, up 25.8% from a year earlier against total liabilities of $110.8 million. Shareholders' equity stood at $1.20 billion, or 91.5% of assets. The company held $272.6 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 10.45, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
IDEAYA Biosciences balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 272.59M | 157.52M | 112.83M | 298.93M | 114.64M | 130.00M | 84.38M | 400.28M | 183.05M | 108.34M | 157.02M | 151.85M |
| Short-Term Investments | 556.37M | 513.68M | 526.56M | 487.97M | 555.09M | 562.51M | 591.94M | 519.75M | 518.61M | 590.43M | 368.10M | 316.90M |
| Receivables | — | — | — | — | — | — | 3.00K | 20.00K | 1.00K | 15.00K | 18.00K | 6.70M |
| Total Current Assets | 864.02M | 696.11M | 666.73M | 802.65M | 685.60M | 707.87M | 689.71M | 932.21M | 713.18M | 709.35M | 532.63M | 482.18M |
| Property, Plant & Equipment | 8.28M | 8.63M | 8.22M | 8.17M | 8.82M | 8.87M | 8.97M | 8.23M | 7.12M | 6.91M | 6.16M | 6.19M |
| Long-Term Investments | 413.93M | 301.71M | 410.30M | 349.96M | 322.13M | 358.67M | 405.83M | 280.13M | 251.07M | 242.64M | 107.49M | 42.39M |
| Total Assets | 1.31B | 1.03B | 1.11B | 1.19B | 1.04B | 1.10B | 1.12B | 1.24B | 973.66M | 961.53M | 649.32M | 532.94M |
| Accounts Payable | 30.51M | 20.74M | 17.58M | 18.43M | 17.27M | 17.63M | 15.42M | 12.57M | 15.89M | 6.29M | 6.60M | 5.17M |
| Total Current Liabilities | 82.68M | 64.83M | 58.81M | 64.51M | 55.34M | 50.85M | 46.07M | 40.66M | 40.74M | 24.96M | 27.10M | 24.89M |
| Total Liabilities | 110.79M | 93.08M | 86.39M | 93.10M | 81.62M | 76.51M | 64.94M | 59.45M | 42.01M | 26.22M | 28.23M | 24.89M |
| Shareholders' Equity | 1.20B | 937.27M | 1.02B | 1.09B | 959.65M | 1.02B | 1.06B | 1.18B | 931.66M | 935.31M | 621.09M | 508.05M |
| Retained Earnings | -947.53M | -835.08M | -736.54M | -653.27M | -772.51M | -695.02M | -622.84M | -492.53M | -440.71M | -387.94M | -348.36M | -314.41M |
| Net Cash (Debt) | 828.96M | 671.20M | 639.39M | 786.89M | 669.74M | 692.51M | 676.32M | 920.03M | 701.66M | 698.77M | 525.11M | 468.75M |
| Shares Outstanding | 96.38M | 87.86M | 87.80M | 87.67M | 87.64M | 87.57M | 86.50M | 86.36M | 76.09M | 74.76M | 65.04M | 58.63M |
This table shows 12 quarterly periods of IDEAYA Biosciences's balance sheet, from Q2 2026 back to Q3 2023, across 14 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow IDYA's reporting calendar. What is a balance sheet?